Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 2
Biotech
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing Deal
Kate Hudson
-
May 1, 2024
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) Amidst Groundbreaking Cancer Therapy Innovations
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks Investor Excitement”
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial Hypertension
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid...
Matt Wade
-
March 20, 2024
0
Is NBIO a Take-Out Target as Phase 1 Brain Cancer Trial...
Matt Wade
-
September 13, 2022
0
The Vaccine Distribution Portfolio (MRNA, XPO, ATVK, FDX)
Gavins Felicity
-
February 22, 2021
0
The Big Picture for Virus Testing Stocks (FLGT, ALST, CODX)
Gavins Felicity
-
February 2, 2021
0
Cancer is Still the Real Global Health Crisis… Four Stocks with...
Gavins Felicity
-
October 7, 2020
0
1
2
3
4
Page 2 of 4
Recent Post
CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics
Ward Sport
-
May 1, 2024
0
Investors and industry watchers are closely monitoring CytomX Therapeutics, Inc. (NASDAQ: CTMX), which has seen a significant uptick in its stock price...
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...
May 1, 2024
GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024
April 30, 2024
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
April 18, 2024
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
April 1, 2024